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An 83-year-old woman was admitted to our hospital because of palpitation. She had
hypertension and paroxysmal atrial ﬁbrillation, treated with digoxin and cibenzoline, and took
dipyridamole for microalbuminuria. Before admission, she had taken pilsicainide pills in
addition. On admission, electrocardiogram showed regular tachycardia with mildly prolonged
QRS width. For the purpose of terminating tachycardia, 10mg of adenosine triphosphate
(ATP) was rapidly injected. About 20 sec later, atrioventricular block and ventricular
standstill occurred. She presented loss of consciousness and convulsion, and chest
compression was performed. About 30 sec later, the QRS complex reappeared, and she
became alert. Serum concentration of digoxin, cibenzoline and pilsicainide was within
therapeutic level, respectively. We should be cautious in using ATP for a patient taking
dipyridamole and antiarrhythmic agents.
(J Arrhythmia 2009; 25: 219–222)
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Introduction
Adenosine has been commonly used to treat
patients with supraventricular tachycardia (SVT).
Because of the very short half-life of adenosine,
serious adverse eﬀects are rarely seen with adeno-
sine used to treatment of SVT.1–3) We report an
elderly women who took dipyridamole and antiar-
rhythmic agents, and presented with prolonged
atrioventricular (AV) block and ventricular standstill
after adenosine triphosphate (ATP) injection.
Case Report
An 83-year-old woman was admitted to our
hospital because of palpitation. She had been
diagnosed with hypertension and paroxysmal atrial
ﬁbrillation and was being treated with antihyperten-
sive agents (candesartan 8mg/day, nifedipine 20
mg/day), digoxin (0.125mg/day) and cibenzoline
(50mg/day) since she was 76-year-old. In addition,
she took dipyridamole (300mg/day) for microalbu-
minuria related to hypertension. Previous electro-
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cardiogram had showed frequent atrial premature
complexes and mild ST depression in II, III, aVF, V5
and V6 leads (Figure 1). Echocardiography showed
normal contractility (ejection fraction 74%) of the
left ventricle without hypertrophy and dilatation, and
left atrial diameter was normal (34mm). Previous
Holter recordings did not show sinus node dysfunc-
tion or atrioventricular block. Cardiac catheterization
was performed when she was 77-year-old. Coronary
angiography showed no organic stenosis of the left
and right coronary arteries, and left ventriculography
showed normal contractility. Before admission, she
took two additional pills of pilsicainide (100mg
total), which were prescribed for her husband in
other hospital. On admission, her height was 150 cm,
body weight was 56 kg, blood pressure was 106/
66mmHg, and heart rate was 114 beats per minute
and regular. Laboratory data indicated normal serum
creatinine level (0.72mg/dl) and mild reduction of
estimated glomerular ﬁltration ratio (58ml/min/
1.73m2). Serum creatine kinase concentration was
within normal range. Electrocardiogram showed
regular tachycardia with mildly prolonged QRS
width (Figure 2). For the purpose of terminating
tachycardia, 10mg of ATP was rapidly (within a few
seconds) injected from right cephalic vein. About
20 sec later, AV block and ventricular standstill
occurred (Figure 3). Atrial ﬂutter was identiﬁed by
its characteristic sawtooth waveform. She presented
loss of consciousness and convulsion, and chest
compression was performed. About 30 sec later,
QRS complexes reappeared during chest compres-
sion, and she became alert. Serum concentration of
digoxin was 1.1 ng/ml (therapeutic level: 0.8–2.0),
cibenzoline was 117.3 ng/ml (70.0–250.0) and pilsi-
cainide was 0.85 mg/ml (0.20–0.90). Dipyridamole
was discontinued, but digoxin (0.125mg/day) and
cibenzoline (50mg/day) were continued for treat-
ment of arrhythmia. Atrial ﬂutter reverted to sinus
rhythm during the ﬁrst day. Holter recording on the
second day did not show sinus node dysfunction,
atrioventricular block and paroxysmal atrial ﬁbrilla-
tion. Thereafter, her clinical course was uneventful.
We have prohibited the use of ATP in this patient.
Discussion
Adenosine is an endogenous nucleoside present
throughout the body and has been commonly used
to treat patients with SVT. Adenosine triphosphate
(ATP) is rapidly converted to adenosine after
exogenous administration and adenosine functions
through its receptor. Adenosine is removed from the
extracellular space by washout, enzymatically by
degradation to inosine, by phosphorylation to ad-
enosine monophosphate, or by reuptake into cells
through nucleoside transport system.4) Because of
the very short half-life (1 to 6 seconds) of adenosine,
serious adverse eﬀects were rare in using adenosine
for treatment of SVT.1–3)
Several serious adverse eﬀects of adenosine were
reported.5) Atrial ﬁbrillation is occasionally observed
with adenosine administration,4) and hemodynamic
deterioration by preexcited atrial ﬁbrillation was
reported in a patient with WPW syndrome.6) Accel-
eration of ventricular response to atrial ﬂutter were
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Figure 1
Electrocardiogram about one year before admission.
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Figure 2
Electrocardiogram on admission showed regular tachycardia with
mildly prolonged QRS width.
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reported in some patients.2,7,8) Adenosine-induced
polymorphic ventricular tachycardia9–11) and ven-
tricular ﬁbrillation12) were reported in a few patients.
To our knowledge, this is the second case report of
prolonged AV block induced by adenosine. Harvey
et al. reported an elderly woman who presented
prolonged complete AV block requiring intubation
and temporary pacemaker after administration of
adenosine for atrial ﬂutter during the treatment with
metoprolol and diltiazem.13) In our patient, digoxin
and cibenzoline were used daily, and she took
pilsicainide temporarily. Although the serum con-
centrations of these agents were all within the
therapeutic level, drug interactions might be related
to this complication. Both cibenzoline and pilsicai-
nide block the sodium channel, digoxin and cibenzo-
line aﬀect muscarinic receptor subtype 2,14) and
pilsicainide potentiates the eﬀect of digoxin. The
potentiated inhibitory eﬀect of these agents on the
AV node and the His-Purkinje system may relate to
prolonged AV block and ventricular standstill. In
this patient, electrocardiogram on admission showed
intraventricular conduction delay which might be
due to the eﬀects of sodium channel blockers
(cibenzoline and pilsicainide). Because adenosine
suppresses His-Purkinje automaticity,15) it may cause
prolonged ventricular standstill in patients with
intraventricular conduction delay.
Dipyridamole is a nucleoside transport blocker
that blocks reuptake of adenosine, delaying its
clearance and potentiating its eﬀect.4) In patients
taking dipyridamole, a lower dose of adenosine is
recommended for treatment of SVT.5) Prolonged
bradycardia (approximately 35 sec) was reported in a
patient who was given adenosine while taking
dipyridamole.16) Because our patient also took
dipyridamole, 10mg of ATP might have been an
overdose for her. Potentiated eﬀect of adenosine
may cause prolonged AV block and ventricular
standstill in this patient.
For prevention of serious adverse eﬀect of ATP,
we have discontinued dipyridamole and prohibited
the use of ATP in this patient. When atrial ﬂutter
recurs, we would recommend catheter ablation for
this patient.
Conclusion
We report an elderly women who presented
prolonged AV block and ventricular standstill
following ATP injection while taking dipyridamole
and antiarrhythmic agents. We should be cautious
in using ATP for patients taking dipyridamole and
antiarrhythmic agents.
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